Literature DB >> 22227165

Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS.

Ying-Yong Zhao1, Jing Liu, Xian-Long Cheng, Xu Bai, Rui-Chao Lin.   

Abstract

BACKGROUND: Chronic renal failure (CRF) is a serious clinical symptom, occurring as the end result of all kinds of chronic kidney disease and its pathophysiological mechanism is not yet well understood. We investigated the metabolic profiling of urine samples from CRF model rats to find potential disease biomarkers and research pathology of CRF.
METHODS: An animal model of CRF was produced by adenine. Metabolic profiling of the urine was performed by using ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC Q-TOF/MS). Acquired data were subjected to principal component analysis (PCA) for differentiating the CRF and the normal control groups. Potential biomarkers were screened by using S-plot and were identified by the accurate mass, isotopic pattern and MS(E) fragments information obtained from UPLC Q-TOF/MS analysis.
RESULTS: 12 metabolites in urine were identified as potential biomarkers. Adenine-induced CRF rats were characterized by the increase of phytosphingosine, adrenosterone, tryptophan, 2,8-dihydroxyadenine, creatinine, and dihydrosphingosine together with the decrease of N-acetylleucine, 3-O-methyldopa, ethyl-N2-acetyl-L-argininate, dopamine, phenylalanine and kynurenic acid in urine. The altered metabolites demonstrated perturbations of amino acids metabolism, phospholipids metabolism and creatinine metabolism in CRF rats.
CONCLUSION: This work shows that metabonomics method is a valuable tool in CRF mechanism study and assists in clinical diagnosis of CRF.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22227165     DOI: 10.1016/j.cca.2011.12.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  40 in total

1.  A high-performance liquid chromatography-tandem mass spectrometry-based targeted metabolomics kidney dysfunction marker panel in human urine.

Authors:  Jacek Klepacki; Jost Klawitter; Jelena Klawitter; Joshua M Thurman; Uwe Christians
Journal:  Clin Chim Acta       Date:  2015-04-11       Impact factor: 3.786

2.  Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis.

Authors:  Xia Liu; Fang Zhong; Xu-long Tang; Fu-lin Lian; Qiao Zhou; Shan-mai Guo; Jia-fu Liu; Peng Sun; Xu Hao; Ying Lu; Wei-ming Wang; Nan Chen; Nai-xia Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-03-17       Impact factor: 6.150

3.  Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease.

Authors:  Ya-Long Feng; Gang Cao; Dan-Qian Chen; Nosratola D Vaziri; Lin Chen; Jun Zhang; Ming Wang; Yan Guo; Ying-Yong Zhao
Journal:  Cell Mol Life Sci       Date:  2019-05-30       Impact factor: 9.261

4.  Efficacy of different hemodialysis methods on dendritic cell marker CD40 and CD80 and platelet activation marker CD62P and P10 in patients with chronic renal failure.

Authors:  Xin-Fang Wang; Bei-Hao Zhang; Xiao-Qing Lu; Pei Wang
Journal:  J Clin Lab Anal       Date:  2018-11-29       Impact factor: 2.352

5.  Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice.

Authors:  Gang Cao; Hua Miao; Yan-Ni Wang; Dan-Qian Chen; Xia-Qing Wu; Lin Chen; Yan Guo; Liang Zou; Nosratola D Vaziri; Ping Li; Ying-Yong Zhao
Journal:  Acta Pharmacol Sin       Date:  2022-05-16       Impact factor: 6.150

6.  Metabolite identification of ursolic acid in mouse plasma and urine after oral administration by ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.

Authors:  Xueyan Hu; Yunbing Shen; Shengnan Yang; Wei Lei; Cheng Luo; Yuanyuan Hou; Gang Bai
Journal:  RSC Adv       Date:  2018-02-08       Impact factor: 4.036

7.  Chronic kidney disease in adolescent and adult patients with phenylketonuria.

Authors:  Julia B Hennermann; Sylvia Roloff; Jutta Gellermann; Ilka Vollmer; Elke Windt; Barbara Vetter; Ursula Plöckinger; Eberhard Mönch; Uwe Querfeld
Journal:  J Inherit Metab Dis       Date:  2012-11-09       Impact factor: 4.982

8.  Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation.

Authors:  Hua Miao; Gang Cao; Xia-Qing Wu; Yuan-Yuan Chen; Dan-Qian Chen; Lin Chen; Nosratola D Vaziri; Ya-Long Feng; Wei Su; Yi Gao; Shougang Zhuang; Xiao-Yong Yu; Li Zhang; Yan Guo; Ying-Yong Zhao
Journal:  Br J Pharmacol       Date:  2020-05-28       Impact factor: 8.739

9.  Urinary metabolomic markers of aminoglycoside nephrotoxicity in newborn rats.

Authors:  Mina H Hanna; Jeffrey L Segar; Lynn M Teesch; David C Kasper; Franz S Schaefer; Patrick D Brophy
Journal:  Pediatr Res       Date:  2013-02-14       Impact factor: 3.756

10.  Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism.

Authors:  Ying-Yong Zhao; Ya-Long Feng; Xu Bai; Xiao-Jie Tan; Rui-Chao Lin; Qibing Mei
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.